Their most recent research, published in EMBO Molecular Medicine, provides the first evidence that an efficacious drug treatment can be developed for this disorder, called CTNNB1 syndrome ...

10-year-old, Matilda Monerawela, was born with a neurodevelopmental disorder due to mutations in the CTNNB1 gene, which is crucial for providing instructions for cell development protein.

Matilda Monerawela, 10, from Torbay, Devon, is one of just 430 individuals worldwide diagnosed with CTNNB1 syndrome ...